Tocilizumab in refractory rheumatoid arthritis: long-term efficacy, safety, and tolerability beyond 2 years

Ziad Farah, Sabreen Ali, Fiona Price-Kuehne, Charles G Mackworth-Young Department of Rheumatology, Charing Cross Hospital, London, UKObjectives: To evaluate the long-term efficacy and safety of tocilizumab (TCZ) in clinical patients with rheumatoid arthritis (RA) refractory to synthetic disease-modi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Farah Z, Ali S, Price-Kuehne F, Mackworth-Young CG
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://doaj.org/article/fe4f2ae821c34e66abc3d3e248d8dcde
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!